Patents Examined by Zabela Schmidt
  • Use of bromodomain-containing protein 9 inhibitors to treat and/or prevent uterine leiomyosarcoma
    Patent number: 12377103
    Abstract: In aspects, the present disclosure provides a method of treating or preventing a uterine leiomyosarcoma in a female mammal, the method comprising, consisting essentially of, or consisting of administering to the female mammal an effective amount of an inhibitor of bromodomain-containing protein 9 (BRD9).
    Type: Grant
    Filed: June 30, 2023
    Date of Patent: August 5, 2025
    Assignee: The University of Chicago
    Inventors: Qiwei Yang, Ayman Al-Hendy